Free Trial

Enovix (NASDAQ:ENVX) Shares Gap Up - Time to Buy?

Enovix logo with Oils/Energy background

Enovix Co. (NASDAQ:ENVX - Get Free Report) shares gapped up prior to trading on Tuesday . The stock had previously closed at $12.46, but opened at $14.15. Enovix shares last traded at $15.66, with a volume of 6,009,226 shares changing hands.

Wall Street Analyst Weigh In

ENVX has been the subject of several recent analyst reports. Benchmark restated a "buy" rating and set a $25.00 target price on shares of Enovix in a research note on Wednesday, October 30th. Cantor Fitzgerald reissued an "overweight" rating and issued a $30.00 price objective on shares of Enovix in a report on Wednesday, October 30th. JPMorgan Chase & Co. cut their target price on shares of Enovix from $18.00 to $15.00 and set an "overweight" rating on the stock in a report on Tuesday, October 22nd. Finally, Janney Montgomery Scott cut shares of Enovix from a "buy" rating to a "neutral" rating and set a $10.00 price target for the company. in a research note on Thursday, October 31st. Two research analysts have rated the stock with a hold rating, eight have issued a buy rating and one has assigned a strong buy rating to the company's stock. Based on data from MarketBeat, the company presently has an average rating of "Moderate Buy" and an average price target of $20.50.

Get Our Latest Report on Enovix

Enovix Stock Up 15.0 %

The company has a market capitalization of $2.55 billion, a price-to-earnings ratio of -8.90 and a beta of 1.86. The company has a debt-to-equity ratio of 0.99, a current ratio of 3.77 and a quick ratio of 3.61. The firm's 50-day simple moving average is $9.65 and its two-hundred day simple moving average is $11.13.

Enovix (NASDAQ:ENVX - Get Free Report) last announced its earnings results on Tuesday, October 29th. The company reported ($0.17) earnings per share for the quarter, beating the consensus estimate of ($0.20) by $0.03. The firm had revenue of $4.30 million during the quarter, compared to the consensus estimate of $4.11 million. Enovix had a negative net margin of 1,180.21% and a negative return on equity of 102.19%. During the same quarter in the previous year, the company posted ($0.27) EPS. Sell-side analysts predict that Enovix Co. will post -1.17 EPS for the current fiscal year.

Insiders Place Their Bets

In related news, insider Arthi Chakravarthy sold 35,000 shares of the company's stock in a transaction that occurred on Monday, October 14th. The shares were sold at an average price of $13.00, for a total transaction of $455,000.00. Following the completion of the transaction, the insider now owns 343,305 shares of the company's stock, valued at approximately $4,462,965. This represents a 9.25 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, Director Betsy S. Atkins sold 75,000 shares of Enovix stock in a transaction on Tuesday, December 3rd. The shares were sold at an average price of $9.73, for a total transaction of $729,750.00. Following the completion of the transaction, the director now owns 99,497 shares in the company, valued at approximately $968,105.81. This trade represents a 42.98 % decrease in their position. The disclosure for this sale can be found here. Corporate insiders own 15.70% of the company's stock.

Institutional Inflows and Outflows

A number of institutional investors have recently made changes to their positions in the company. Prospera Private Wealth LLC acquired a new position in Enovix in the 3rd quarter worth $27,000. Strategic Investment Solutions Inc. IL acquired a new position in shares of Enovix in the second quarter worth about $39,000. Voisard Asset Management Group Inc. grew its stake in Enovix by 40.0% during the 3rd quarter. Voisard Asset Management Group Inc. now owns 7,000 shares of the company's stock valued at $65,000 after purchasing an additional 2,000 shares in the last quarter. Quest Partners LLC grew its stake in Enovix by 318.5% during the 3rd quarter. Quest Partners LLC now owns 8,270 shares of the company's stock valued at $77,000 after purchasing an additional 6,294 shares in the last quarter. Finally, Headlands Technologies LLC purchased a new stake in Enovix during the 2nd quarter worth approximately $97,000. 50.92% of the stock is owned by institutional investors and hedge funds.

About Enovix

(Get Free Report)

Enovix Corporation designs, develops, and manufactures lithium-ion batteries. It serves wearables and IoT, smartphone, laptops and tablets, industrial and medical, and electric vehicles industries. The company was founded in 2007 and is headquartered in Fremont, California.

Featured Stories

Should You Invest $1,000 in Enovix Right Now?

Before you consider Enovix, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Enovix wasn't on the list.

While Enovix currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Beginners Guide To Retirement Stocks Cover

Enter your email address and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Palantir’s Explosive Growth: Buy Now or Wait for a Dip?
5 Stocks to BUY NOW in February 2025
How To Invest in Crypto as A Complete BEGINNER in 2025

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines